What is the HAE stock price prediction for next 2 weeks?

According to our price prediction algorithm,Haemonetics Corporation (HAE) price will be around $54.43 in the next 2 weeks. This means it will decrease by -8.28008088978767 from the last closing price. This prediction may vary from other time period filters for HAE stock.

What can be the highest Possible price of HAE stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, HAE can achieve the highest price of $56.78 which is -4.314846840985355 lower than last closing price. This prediction may vary from other time period filters for HAE stock.

What can be the lowest Possible price of HAE stock in next 2 weeks?

As per the forecast and algorithmic analysis, HAE stock price can be as low as $52.35 which is -11.77401094651271 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for HAE stock.

Will HAE stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that HAE stock will lose-8.28008088978767 in the next 2 weeks. This prediction may vary from other time period filters for HAE stock.

What is HAE stock last closing price?

Last closing price of HAE stock was $57.69.

What is HAE stock price prediction?

HAE stock price prediction means predicting the future closing prices of HAE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of HAE stock in a certain time period.

How we predict HAE stock future prices?

If you are searching for HAE stock forecast, analysis or price prediction, then you might be wondering what Haemonetics Corporation (HAE) will do in the future. Our HAE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This HAE price prediction will likely answer most of your questions.

How frequent we update HAE stock predictions?

We are updating the forecasts for the HAE stock on daily basis.

Is using ML forecasting for HAE stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for HAE stock same for all the time periods?

No, the prediction for HAE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Haemonetics Corporation Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$57.69-15.62%Since 2 Weeks

Predicted Price$54.43-8.28%For 2 Weeks

Upper Predicted Price$56.78-4.31%For 2 Weeks

Lower Predicted Price$52.35-11.77%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of HAE will decline by -8.28% over the next 2 Weeks and hit $54.43 by Friday, February 20, 2026. In that time frame, HAE's share price is expected to range between $52.35 and $56.78.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 23, 2026	50.01	52.45	54.96
Feb 20, 2026	50.22	52.58	54.85
Feb 19, 2026	51.48	53.58	55.80
Feb 18, 2026	51.57	53.59	55.60
Feb 17, 2026	52.51	54.33	56.32
Feb 16, 2026	53.65	55.45	57.25
Feb 13, 2026	53.83	55.58	57.33
Feb 12, 2026	54.86	56.58	58.15
Feb 11, 2026	54.94	56.59	58.21
Feb 10, 2026	55.71	57.33	59.01

HAE shares fell -2.78% in Monday, February 9, 2026's trading session, dropping from a previous close of $59.34 to move at $57.69. The stock demonstrated notable intraday movement (see HAE's key stats for a full breakdown), fluctuating between $56.99 and $59.64, a +4.66% trading range. While recent weeks have seen some volatility, HAE has managed to secure a -15.00% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.49M shares changing hands, 282.13K fewer than the previous session. This amounted to $86.07M in total market activity.

Will HAE Continue Its Downward Trend?

According to analyst ratings and projections for HAE, Haemonetics Corporation shares are anticipated to decrease by -4.97%, potentially reaching $54.96 per share by February 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for HAE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the HAE stock forecast, now is not the best time to buy HAE stock because its current trading price is +10.00% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on HAE covering social and institutional perspectives.

HAE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into HAE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 11.81% to 23.11%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 39.62%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 45.21%, maintains a neutral outlook for the long term. Insights into HAE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Haemonetics Short-Term Forecasts

HAE Forecast For Next 5 Days

Our algorithm anticipates Haemonetics (HAE) stock could hit $46.63 by Feb 16, 2026. This represents a -19.18% fall from today's price, following a -15.46% change over the past five days.

HAE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Haemonetics Corporation (HAE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $47.95, which would mean a -16.88% decrease from the current price of $57.69. Projections for this period range from a high of $58.97 to a low of $39.76.

HAE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Haemonetics's price over the next three months point to a rise. HAE stock is expected to peak at $64.78 on May 06, 2026 after potentially dipping to $53.16 on Apr 01, 2026. On average, HAE is likely to trade around $58.66 in the coming 90 days.

Haemonetics Stock Forecast 2025

Based on our predictive models, Haemonetics (HAE) is expected to trade between $48.17 and $68.49 throughout 2026. This would result in an average price of $56.60, potentially offering investors a -1.89% return from current levels.

Haemonetics Corporation Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, Haemonetics Corporation (HAE) is positioned to show a strong performance in February 2026. The price is predicted to move between $53.85 and $62.09, settling at an average of $58.02. This could translate to a +0.57% gain.

March 2026

Based on current market signals, Haemonetics Corporation is projected to trend march 2026. We forecast a trading range from $53.60 to $63.20, with a likely average price of $58.13. Investors could expect a potential return of +0.76%.

April 2026

Our predictive algorithms indicate Haemonetics Corporation stock may see a shift in April 2026. The expected range spans $53.16–$64.46, with an average target of $59.01. This represents a positive outlook and a possible gain of +2.29%.

May 2026

Analyzing established trends, Haemonetics Corporation looks set to move in May 2026. Projections place the stock between $56.13 and $65.01, averaging around $60.64. This suggests a +5.11% gain from current levels.

June 2026

Market indicators suggest Haemonetics Corporation could experience notable changes during June 2026. Prices could fluctuate within $51.72 to $65.62, with a midpoint forecast of $57.63. The stock might deliver a -0.10% loss.

July 2026

Forecasting for July 2026, models estimate that Haemonetics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $50.99 and $59.01, averaging $55.13. This signals a cautious trajectory with potential returns around -4.44%.

August 2026

According to our latest forecast models, Haemonetics Corporation (HAE) is positioned to show a strong performance in August 2026. The price is predicted to move between $50.51 and $59.63, settling at an average of $54.83. This could translate to a -4.96% loss.

September 2026

Based on current market signals, Haemonetics Corporation is projected to trend september 2026. We forecast a trading range from $50.37 to $61.42, with a likely average price of $56.22. Investors could expect a potential return of -2.55%.

October 2026

Our predictive algorithms indicate Haemonetics Corporation stock may see a shift in October 2026. The expected range spans $50.41–$62.04, with an average target of $57.44. This represents a cautious outlook and a possible loss of -0.43%.

November 2026

Analyzing established trends, Haemonetics Corporation looks set to move in November 2026. Projections place the stock between $48.28 and $68.49, averaging around $54.32. This suggests a -5.84% loss from current levels.

December 2026

Market indicators suggest Haemonetics Corporation could experience notable changes during December 2026. Prices could fluctuate within $48.17 to $56.18, with a midpoint forecast of $52.05. The stock might deliver a -9.78% loss.

January 2027

Forecasting for January 2027, models estimate that Haemonetics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $47.31 and $56.22, averaging $51.47. This signals a cautious trajectory with potential returns around -10.78%.

February 2027

According to our latest forecast models, Haemonetics Corporation (HAE) is positioned to show a strong performance in February 2027. The price is predicted to move between $47.71 and $56.20, settling at an average of $52.08. This could translate to a -9.72% loss.

HAE's history of dividends and stock splits also plays a role in long-term investor confidence.